Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib vs Diclofenac in Ankylosing Spondylitis
NCT02528201Phase 4Completed
- Sponsor
- Pfizer
- Start
- Sep 2002
- Primary completion
- Nov 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of celecoxib in ankylosing spondylitis (AS), sponsored by Pfizer. Started Sep 2002; status: completed.
02
Drugs
celecoxib
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT02528201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02528201.